ANUH PHARMA
Back to Balance Sheet
|
ANUH PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-2.08 Cr | ₹-0.42 Cr | ₹-0.77 Cr | ₹0.05 Cr | ₹1.01 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ANUH PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-2.08 Cr |
| Mar2024 | ₹-0.42 Cr |
| Mar2023 | ₹-0.77 Cr |
| Mar2022 | ₹0.05 Cr |
| Mar2021 | ₹1.01 Cr |
How is Deferred Tax Assets / Liabilities of ANUH PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.08 Cr | Negative | |
| Mar2024 | ₹-0.42 Cr | Negative | |
| Mar2023 | ₹-0.77 Cr | Negative | |
| Mar2022 | ₹0.05 Cr | -95.27 | |
| Mar2021 | ₹1.01 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ANUH PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ANUH PHARMA | ₹803.7 Cr | 0.3% | 4.8% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
ANUH PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ANUH PHARMA | 0.3% |
4.8% |
-21.7% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses